Showing results (71-80 of 90) with videos related to
Sort By:
Pageof 9
The Journal of Clinical Endocrinology and Metabolism|March 20, 2025
Immune checkpoint inhibitor therapy for aggressive pituitary neuroendocrine tumorsAndrew L Lin, Vasilisa Rudneva, Adam Newton, et al.Acta Neuropathologica|March 10, 2012
Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastomaShyamal Dilhan Weeraratne, Vladimir Amani, Natalia Teider, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2024
A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade GliomasPankaj B Desai, Aniruddha S Karve, Misam Zawit, et al.Neuro-Oncology Advances|January 28, 2021
Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trialGary L Gallia, Matthias Holdhoff, Henry Brem, et al.Cancers|August 10, 2024
VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in MedulloblastomaNatalia Muñoz Perez, Juliana M Pensabene, Phillip M Galbo, et al.International Journal of Radiation Oncology, Biology, Physics|February 15, 2020
Impact of Sequencing Radiation Therapy and Immune Checkpoint Inhibitors in the Treatment of Melanoma Brain MetastasesDaniel A Pomeranz Krummel, Tahseen H Nasti, Benjamin Izar, et al.Cancer|April 29, 2020
Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classificationRobert H Press, Sarah L Shafer, Renjian Jiang, et al.Neuron|September 5, 2006
A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegenerationStanislav L Karsten, Tzu-Kang Sang, Lauren T Gehman, et al.International Journal of Radiation Oncology, Biology, Physics|December 8, 2020
Melanoma Cell Intrinsic GABA<sub>A</sub> Receptor Enhancement Potentiates Radiation and Immune Checkpoint Inhibitor Response by Promoting Direct and T Cell-Mediated Antitumor ActivityDaniel A Pomeranz Krummel, Tahseen H Nasti, Milota Kaluzova, et al.Biorxiv : the Preprint Server for Biology|December 11, 2023
GABA(A) receptor activation drives GABARAP-Nix mediated autophagy to radiation-sensitize primary and brain-metastatic lung adenocarcinoma tumorsDebanjan Bhattacharya, Riccardo Barille, Donatien Kamdem Toukam, et al.Pageof 9